Autolomous
George Eastwood serves as the Executive Director of the Emily Whitehead Foundation from June 2021 to December 2024. In addition, George holds multiple leadership roles as the Chair of the Board of Directors and Board Member for the Alliance for Regenerative Medicine, and serves as a Board Member for TrueTrials, an organization focused on facilitating patient enrollment in FDA-authorized clinical trials. Since April 2023, George has been a Non-Executive Board Member at Autolomous and previously worked as the Chief Commercial Officer at Excellos from November 2021 to October 2022, where responsibilities included fundraising and strategy. George earned a Bachelor of Science degree in Toxicology from Northeastern University in January 2004.
This person is not in any teams
This person is not in any offices
Autolomous
2 followers
Autolomous is enabling ATMP Manufacturers bring Cell and Gene Therapies to more patients.